BEAM vs IP · rev $63.5M vs P/E 43, $26.62B cap
Beam Therapeutics Inc (BEAM) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
IP does not have a complete income-statement cache yet.
BEAM currently screens at market cap $2.01B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the BEAM and IP stock pages for the full models.
Not investment advice.